There is one clinical trial.
To determine whether the use of oxygen hoods as compared to conventional high-flow oxygen delivery systems, and the effects on oxygenation, mechanical ventilation and mortality rates in hypoxic patients with COVID-19.
Description: Continuous pulse oximetry monitoringMeasure: Oxygen saturation Time: 3/6/2020 - 5/1/2020
Description: Intubation/mechanical Ventilation at any point during hospitalization.Measure: In-hospital Intubation/Mechanical Ventilation Status Time: 3/6/2020 - 5/1/2020
Description: In-hospital Mortality statusMeasure: In-hospital Mortality Time: 3/6/2020 - 5/1/2020
Description: Duration of hospitalizationMeasure: Length of Hospitalization Time: 3/6/2020 - 5/1/2020
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports